KEFLIN NEUTRAL INJ 2GM/VIAL DIN 00244406
Health Canada record
| Active ingredient(s) | CEPHALOTHIN SODIUM 2 G |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intramuscular; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01DB03 CEFALOTIN |
| Original market date | 31-Dec-1975 |
| Current status date | 23-Sep-1996 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eli Lilly Canada Inc. — licence 100164, currently licensed, last inspection rating C (2026-03-24).
No Canadian shortage report is currently matched to this DIN.
International API supply for CEPHALOTHIN SODIUM
2 active FDA Drug Master Files.
Request a quote for KEFLIN NEUTRAL INJ 2GM/VIAL